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Abstract 27
Aims 28
Thrombopspondin-4 (TSP4) is a pro-angiogenic protein that has been implicated in 29 tissue remodeling and local vascular inflammation. TSP4 and, in particular, its SNP 30 variant, P387 TSP4, have been associated with cardiovascular disease. 31
Macrophages are central to initiation and resolution of inflammation and development of 32 atherosclerotic lesions, but the effects of the P387 TSP4 on macrophages remain 33 essentially unknown. We examined the effects of the P387 TSP4 variant on 34 macrophages in cell culture and in vivo in a murine model of atherosclerosis. Further, 35
the levels and distributions of the twoTSP4 variants were assessed in human 36 atherosclerotic arteries. 37
Methods and Results 38
In ApoE -/-/P387-TSP4 knock-in mice, atherosclerotic lesions accumulated more 39 macrophages than lesions bearing A387 TSP4. The levels of inflammatory markers 40
were increased in lesions of ApoE -/-/P387-TSP4 knock-in mice compared to ApoE -/-41 mice. Lesions in human arteries from individuals carrying the P387 variant had higher 42 levels of TSP4 and higher macrophage accumulation. P387 TSP4 was more active in 43
supporting adhesion of cultured human and mouse macrophages in experiments using 44 recombinant TSP4 variants and in cells derived from P387-TSP4 knock-in mice. 45
Conclusions 46
TSP4 supports the adhesion of macrophages and their accumulation in atherosclerotic 47
lesions. P387 TSP4 is more active in supporting these pro-inflammatory events in the 48 vascular wall, which may contribute to the increased association of P387 TSP4 with 49 cardiovascular disease. 50
Introduction 58
Thrombospondin-4 (TSP4) is a matricellular protein from the thrombospondin (TSP) 59
family, which consists of five homologous but differentially expressed members that are 60 products of five different genes on different chromosomes (1, 2) . Recent studies have 61 demonstrated the importance of TSP4 in the cardiovascular system (3-17), cancer (15, 62
18-27), and the nervous system (28-32). These reports have placed considerable 63 attention on this poorly studied TSP, but many of its functions and its regulation still 64 remain unknown. Our previous work in Thbs4 -/mice (17) revealed that TSP4 promotes 65 atherosclerotic lesions, regulates the local vascular inflammation, and supports 66 accumulation of macrophages in atherosclerotic lesion. 67
The effects of TSP4 depend on its interaction with cellular receptors and ligands in the 68 extracellular matrix (ECM). P387-TSP4, a SNP variant common in North American 69 population (3, 6) has been associated with myocardial infarction (MI) and coronary 70 artery disease (CAD) (3-10). Previously, we reported that P387-TSP4 is less 71
susceptible to proteolysis and is more active in regulating cellular functions (14, 33-35).
72
Here, we used P387-TSP4 knock-in (KI) mice and recombinant P387-TSP4 to examine 73 the activity of this variant in atherosclerosis. We compared the effects of TSP4 variants 74 not only in mouse but also in human atherosclerotic arteries and identified both 75 commonalities and differences in the effects of the TSP4 variants on macrophages. 76
Materials and Methods 77

Animals: 78
Mice were in a C57BL/6 background. Both genders were used, but no gender-specific 79 differences were detected. Thbs4 −/− mice were described previously (14-17, 36). Control 80 wild-type (WT) mice were from the same mouse colony as Thbs4 −/− mice or P387-TSP4-81 KI mice. For experiments exclusively using WT mice, WT C57BL/6 mice were purchased 82 from the Jackson Laboratories. Animals were housed in the AAALAC-approved animal 83
facilities of the Cleveland Clinic. Animal procedures were approved by the Institutional 84
Animal Care and Use Committee of the Cleveland Clinic and were in accord with the NIH 85
Guide for Animal Use. Ketamine (100 mg/kg)/Xylazine (15 mg/kg) was used for 86 anesthesia. 87
Atherosclerosis model and analysis of the lesions: 88
For the analysis of atherosclerotic lesions, four groups of mice (n ≥ 13) were analyzed; 89
ApoE −/− and P387-TSP4-KI/ApoE −/− mice were maintained either on a regular chow or a 90
Western diet (TD88137, Teklad Diets, Madison, WI). All mice were analyzed for 91 development of atherosclerosis at 20 weeks of age, 16 weeks after being placed on the 92 two diets. In mice on both diets, lesions that developed in the aortic root, aortic arch, 93
descending aorta and femoral artery were measured. At 20 weeks of age, the 94 circulatory system of anesthetized mice was perfused with 0.9% NaCl by cardiac 95 intraventricular cannulation. Surface lesion area was determined by an en face method. 96
Oil Red O-stained areas of lesions were quantified using ImagePro 6.3. 97
Genotyping: 98
Genomic DNAs were extracted from frozen tissue samples using Qiagen DNeasy kit.
99
TSP4 A387P mutations were detected using rhAmp™ SNP Assay (SNP id: rs1866389, 100
Integrated DNA Technologies) kit with Quantstudio 5 cycler genotyping program 101
according to assay protocol set by the manufacturer. Genotyping calls were made by 102 the automated program with standards (WT and A387P variant) set with gBlocks™ 103
Gene Fragments (Integrated DNA Technologies) as suggested by manufacturer's 104 instructions for the kit. 105
Human Coronary Artery Samples: 106
A total of 24 fresh human coronary artery samples were obtained from the 107
Histochemistry Core of the Department of Biomedical Engineering of the Cleveland 108
Clinic, embedded in Tissue-Tek® O.C.T. Compound (#4583, Sakura Finetek) followed 109 by flash freeze in liquid nitrogen. Frozen tissue section, 10 μm thickness, were cut with 110 microtome and mounted on slides for immuno-histochemical or immunofluorescence 111 staining. 112
Blood cell count: 113
200 µl of blood was collected from heart into 0.6 ml snap cap aliquot tubes. EDTA 114 coated syringes were used. Samples were analyzed within one hour of collection. Cells 115
were counted in the Laboratory Diagnostics Core at the Cleveland Clinic using Advia 116 hematology analyzer. 117
Human blood-derived monocyte isolation: 118
Blood monocytes were isolated using Ficoll Paque, and total number of cells were 119
counted. 120
Cell Culture and Cell Lines: 121
Human macrophage-like cell line WBC264-9C were purchased from ATCC (Virginia, 122 USA). Eagle's Minimum Essential Medium (WBC264-9C), supplemented with 10% fetal 123 bovine serum (FBS), sodium bi-carbonate (1.5gm/L), 100 U/mL penicillin, and 124 100 µg/mL streptomycin, was used for culture at 37 °C in 5% CO2 atmosphere 125 according to ATCC recommendations. All experiments were done with cells between 126 passages 4 and 8. 127
Isolation of Peritoneal Mouse Macrophages: 128
Mouse peritoneal macrophages (MPM) were isolated from WT, Thbs4 −/− and P387-TSP4-129
KI mice and directly used for adhesion and migration experiments. MPM were derived 130 from mice treated with LPS (0.25 µg/g) for 72 hours by peritoneal lavage with PBS. 131 Initial attachment of cells was determined after 3 hours using CyQUANT live cell 132 quantification kits. Each group of live cells was normalized to its respective 3 hours initial 133 attachment to account for the differences in initial adhesion of macrophages. 134
Purification of recombinant TSP4 variants: 135
Recombinant TSP4 (rTSP4) variants were purified from culture supernatants of HEK293 136 cells stably transfected with A387-and P387-coding cDNA of TSP4 as was described in 137 our earlier publications (27, 33, 34). 138
In vitro adhesion assays 139
Adhesion assays were performed as previously described (14, 15, 17, 33, 35) . For 140 human blood monocytes, 1×10 5 cells/well in 100 µl of DMEM-F-12 medium containing 141 10% FBS were added to 96-well TC-nontreated plates (Becton Dickinson, Franklin 142
Lakes, NJ) coated with immobilized purified recombinant P387 TSP4 or A387 TSP4. 143
The wells were coated with 100 µl P387 TSP4 or A387 TSP4 (10 µg/ml) for 2 hours at 144 37ºC, post-coated with 0.5% polyvinylpyrrolidone for 1 hour at 37ºC, washed twice with 145 PBS, and incubated for 0.5 or 4h at 37ºC (33-36). Non-adherent cells were aspirated 146 and 150 µl of Hanks balanced saline solution containing 1 mM Mg 2+ , 1 mM Ca 2+ and 147 0.1% bovine serum albumin (BSA) were added to each well. 148
H2O2 release 149
H2O2 was measured in the supernatants of adherent human monocytes after 48 hours 150
using the Amplex Red Hydrogen Peroxide/Peroxidase Assay Kit (Thermofisher 151
Scientific, Grand Island, NY), according to manufacturer's instructions. 152
In vitro migration assays 153
Cells were suspended in the serum-free DMEM and transferred into the trans-well 154 chambers (Corning, Corning, NY, USA). FBS (20%) was used as a chemo-attractant in 155
the bottom chambers. The cells were incubated at 37 °C for 4 hr, the medium was 156 aspirated, and attached cells were removed from the surface of the upper chamber 157
using Q-tips. The plates were frozen at − 80 °C for 3 hours, and DNA of remaining cells 158 was quantified using CyQUANT reagent (Invitrogen, Carlsbad, CA, USA). 159
Immunohistochemistry, immunofluorescence, confocal imaging and 160 quantification of macrophage markers 161
Sections of aortic lesions were stained with primary rat anti-mouse CD68 (MCA1957B, 162
Bio-Rad), rabbit anti-mouse CD38 (bs-0979R, Bioss Antibodies), rabbit anti-mouse Egr2 163
(ab90518, Abcam), rabbit anti-mouse MCP-1 (Abcam), or rabbit anti-mouse NF-kB p65 164
(phospho S536, Abcam) antibody. For human arteries staining, rabbit anti-human vWF 165 antibody (A0082, Dako), mouse anti-human CD68 (Dako) and goat anti-humanTSP4 166 (AF2390, R&D Systems) (1:200) were used followed by the treatment with Vecta Stain 167 ABC Kit. Visualization after staining with the antibodies was performed using a high-168
resolution Aperio AT2 slide scanner (Leica Microsystems, GmbH, Wetzlar, Germany). 169
Images of whole slides at 20x magnification were scanned, and the staining was 170 quantified to determine the percentage of stained area using Image Pro and Adobe 171
Photoshop CS6 (Media Cybernetics Fluor TM 647 F(ab')2 fragment of goat anti-mouse IgG(H+L) (A21237, Invitrogen) and 181
Alexa Fluor TM 647 chicken anti-rabbit IgG (H+L) (A21443, Invitrogen). Images were 182 taken at a high resolution confocal microscope (Leica DM 2500) at 63x magnification. 183
All sections with primary antibodies were incubated for 2 hours at 4°C followed by 184
incubating sections in secondary antibodies for 45 min at 4°C. 185
Statistical analysis 186
Group size was calculated based on the previous data obtained in mouse models ( 
P387 TSP4 promotes accumulation of macrophages in atherosclerotic lesions 195 of ApoE -/mice: 196
ApoE -/-(A387) and ApoE -/-/ P387-TSP4-KI mice were fed with either chow or western 197 diet for 16 weeks, starting at 4 weeks of age. Atherosclerotic lesions in aortic arch, 198
descending aorta, and femoral artery of the two genotypes were stained with Oil Red O 199
and quantified as described in Methods. There was no difference in the size of lesions 200 between the two genotypes on either diet (Fig.1A shows the results for mice on Western 201 diet). However, when the cellular content of the lesions was evaluated, the lesions of 202
ApoE -/-/ P387-TSP4-KI mice were found to contain significantly more cells than the 203 lesions of ApoE -/mice. Immunostaining with anti-CD68 (marker of macrophage) and 204
anti-a-smooth muscle actin (a-SMA) revealed that the number of both cell types was 205
higher in ApoE -/-/ P387-TSP4-KI mice (Fig.1B) . 206
Blood cell counts were performed in Thbs4 -/and P387-TSP4-KI mice to determine 207
whether the higher accumulation of macrophages in lesions may reflect the higher 208 numbers of leukocytes and/or monocytes in blood. There was no difference between 209 the leukocyte, monocyte, or lymphocyte numbers in P387-TSP4-KI and the 210 corresponding WT control mice (Table 1 ). In Thbs4 -/mice that had lower macrophages 211 accumulation in lesions (17), the number of leukocytes was significantly higher 212 compared to corresponding control WT mice. There was no significant difference in 213 monocytes numbers, and the difference in leukocyte numbers was attributable to a 214 significant difference in lymphocytes counts. 215
Levels of CD38, a marker of pro-inflammatory macrophages, are increased in 216 lesions of ApoE -/-/ P387-TSP4-KI mice: 217
Co-localization of CD68, a marker of macrophages, and CD38, a marker of pro-218 inflammatory immune cells was examined in atherosclerotic lesions of mice of both 219 genotypes using immunofluorescence and confocal microscopy ( Fig.2A ). CD38 staining 220
was associated with macrophages in the lesions. Presence of Egr2, a marker of tissue 221
repair macrophages, was also analyzed (Fig.2B ). Egr2 expression was found in 222 macrophages as well as in other cell types, especially in smooth muscle cells. 223
The accumulation of pro-inflammatory macrophages was increased in ApoE -/-/ P387-224
TSP4-KI mice compared to ApoE -/mice expressing A387 TSP4: the level of CD38, a 225 marker of pro-inflammatory macrophages, was significantly increased (Fig.3A , p = 226 0.007). The level of a marker of tissue repair macrophages, Egr2, was decreased, 227
although this decrease did not reach statistical significance with n = 10 ( Fig. 3B , p = 228 0.08). 229
Increased levels of inflammatory markers in lesions of ApoE -/-/ / P387-TSP4-KI 230 mice: 231
The levels of MCP-1, p65, and ICAM-1 were visualized in lesions of ApoE -/-/ P387-232
TSP4-KI mice and ApoE -/mice expressing A387 TSP4 by immunohistochemistry with 233
anti-MCP-1, anti-p65, and anti-ICAM-1 antibodies as described in Methods. The 234
percentage of stained area of lesions was quantified (Fig.4) . The levels of MCP-1, p65, 235 and ICAM-1 were significantly higher in ApoE -/-/ P387-TSP4-KI mice than in ApoE -/-236 mice. 237
P387 TSP4 is associated with higher accumulation of macrophages in human 238 coronary arteries: 239
Left anterior descending coronary arteries were collected post-mortem after accidental 240 death and genotyped to identify the vessels expressing P387 TSP4. Out of 23 collected 241 vessels, 6 were heterozygous (HT). TSP4 and macrophages were visualized by 242 immunofluorescence (Fig. 5 ) and immunohistochemistry (Fig. 6) . 243
In homozygous arteries expressing A387 TSP4 only, TSP4 was localized to 244 endothelium and adventitia (Fig. 5A) . In HT arteries, the levels of TSP4 were higher and 245 easily detectable in all layers of the artery (Fig. 5B) . In both genotypes, we detected the 246 expression of TSP4 in macrophages (co-staining with anti-CD68 antibody), in addition 247
to endothelial cells (EC, co-staining with anti-vWF antibody) and some vascular smooth 248 muscle cells in tunica media (Fig. 5B ). 249 TSP4 immunostaining was quantified in arteries. More TSP4 was detected in HT 250 arteries, and higher levels were associated with atherosclerotic lesions than in the 251 homozygous A387 TSP4 arteries (Fig. 6A ). Macrophage accumulation correlated with 252
TSP4 levels in the vessels: it was significantly increased in HT arteries, both in the 253 tunica intima (Fig. 6B ) and tunica adventitia (Fig. 6C) , and was higher in atherosclerotic 254 lesions ( Fig. 6B and C) . 255
P387 TSP4 is more active in supporting the adhesion of monocytes and 256 macrophages: 257
In seeking an underlying mechanism for the increased accumulation of macrophages 258
with the P387 TSP4 variant, we compared the effects of A387 TSP4 and P387 TSP4 on 259 monocyte/macrophage adhesion, migration, and activation using a macrophage-like cell 260 line and mouse peritoneal macrophages. 261
The adhesion of human blood monocyte and the macrophage-like cells WBC264-9C 262 was increased on recombinant P387 TSP4 (rTSP4) ( Fig.7A and B ). In the presence of 263 P387 rTSP4, adhesion was associated with significantly higher H2O2 levels, even when 264 corrected for differences in the number of adherent cells (Fig.7A ), although both A387 265 and P387 TSP4 supported the adhesion of monocytes/macrophages and H2O2 266 production compared to wells coated with BSA. 267 When peritoneal macrophages from WT, Thbs4 -/-, and P387-TSP4-KI mice were used in 268 adhesion and migration assays, both adhesion and migration were reduced in Thbs4 -/-269 mice compared to WT mice (Fig.7C) . Cells from P387-TSP4-KI mice demonstrated 270 increased adhesion, but did not have higher migratory capacity than cells from WT 271 mice. 272 273 274
Discussion 275
In comparison to TSP1, the first discovered TSP (37) with a readily available source for 276 purification from platelets, functions of TSP4 are poorly studied. However, recent 277
reports stressing the importance of TSP4 in cardiovascular system (3-17), in cancer (15, 278
18-27), and in nervous system (28-32) have attracted a lot of attention to this 279 matricellular protein. Although differences in the secondary and tertiary structure 280 between TSP1 and TSP4 (1, 2, (38) (39) (40) (41) suggested that their functions may be different 281 too, only very recently have such differences been demonstrated experimentally. TSP4 282 was found to be pro-angiogenic (15, 27), unlike TSP1, which is a potent anti-angiogenic 283 protein (42, 43). The role of TSP4 in inflammation was also reported to be different from 284
the role of TSP-1. TSP1 promotes the resolution of inflammation in several animal 285 models (44-46), while TSP4 was found to increase local vascular inflammation in 286 atherosclerosis model. Specifically, atherosclerotic lesions in ApoE -/mice deficient in 287 TSP4 were less cellular, contained fewer macrophages, and had reduced levels of 288 inflammatory markers (17). 289 P387 SNP variant of TSP4 has been associated with increased risk of myocardial 290 infarction and cardiovascular disease (3-10). We found that this variant of TSP4 is more 291 active in its cellular interaction and effects on neutrophils and endothelial cells (14, 33-292 35). The effects of P387 TSP4 in atherosclerosis and its interaction with macrophages 293
has not been previously characterized. Here, we examined the effect of P387 TSP4 on 294 atherosclerotic lesions in ApoE -/mice and in human arteries from P387 carriers. A387 295 TSP4 increased early lesions in mice on chow diet, but was more inflammatory in lesion 296 of mice on a Western diet, TSP4 increased macrophage accumulation without affecting 297 the size of lipid lesions (17). Similar to WT A387 TSP4, P387 TSP4 did not change the 298 size of atherosclerotic lesions visualized by Oil Red O staining. However, the cellularity 299 of lesions was increased, and the immunostaining for CD68 revealed significant 300 increase of macrophage accumulation in lesions of P387-TSP4-KI mice. The increased 301 accumulation of macrophages in lesions supports our earlier observations of higher 302 activity of P387 TSP4 compared to A387 TSP4 (14, 33-35). 303 P387 is a common SNP: initial study identified the prevalence of this variant at 34% in 304 the US Caucasians population (6). P387 TSP4 variant acted as dominant and produced 305 its CVD effects in heterozygous individuals. We collected and genotyped left anterior 306 descending coronary arteries post mortem and identified a group of heterozygous (HT) 307 P387 carriers. The localization of P387 TSP4 was similar to that of A387 TSP4 by 308
immunofluorescence. We found that both variants accumulated in tunica adventitia, in 309
luminal endothelial cells, and in tunica intima of atherosclerotic arteries. In both t. 310
adventitia and t. intima, both variants of TSP4 were associated with macrophages, 311 among other cells (e.g., smooth muscle cells and endothelial cells also known to 312 produce TSP4)(16, 17, 35, 36). Quantification of macrophages in t. adventitia and t. 313
intima using staining with macrophage marker CD68 revealed increased accumulation 314 of macrophages in HT arteries within atherosclerotic lesions compared to homozygous 315 A387 carriers or to the levels in arteries without lesions. The levels of P387 TSP4 in 316
vessel wall were higher than the levels of A387 TSP4, probably reflecting the lower 317 susceptibility of P387 TSP4 to proteolysis that we had noticed earlier (34). Furthermore, 318
higher levels of P387 TSP4 allowed us to detect TSP4 production by macrophages. To 319 date, production of TSP4 by the blood cells has not been reported. Additionally, 320
quantification of markers of pro-inflammatory macrophages (CD38) and tissue repair 321 macrophages (Egr2) revealed increased accumulation of pro-inflammatory 322 macrophages associated with P387 TSP4. CD38 expression was associated with 323 macrophages in lesions, while Egr2 was produced by both macrophages and other cell 324
type, e.g., smooth muscle cells, which probably resulted in overestimation of tissue 325
repair macrophages presence. Taken together with the previously reported effects of 326
WT A387 TSP4 on vascular inflammation (17), these results suggested not only higher 327
activity of P387 TSP4 in lesions but also the association of TSP4, especially P387 328 TSP4, with accumulation of pro-inflammatory macrophages in vascular tissue. 329
In addition to the increased number of the macrophages and the change in balance of 330
pro-inflammatory and tissue-repair macrophage phenotypes, higher inflammation in the 331 vessels of mice carrying P387 variant was demonstrated by increased levels of MCP-1, 332
ICAM-1-1 and active p65 NFkB. 333
The observed association between TSP4 (17), especially P387 TSP4, and the 334 increased accumulation of macrophages, suggested that the adhesive properties of 335 these matricellular proteins might contribute to the enhanced macrophage content of 336 atherosclerotic lesions. Earlier, we had reported increased adhesive activity of P387 337
TSP4 versus A387 TSP4 for neutrophils (33) and endothelial cells (14, 35) . Using a 338 macrophage-like cell line, primary mouse macrophages, and human monocytes, we 339
found that TSP4 supported the adhesion of macrophages and monocytes. P387 was 340 significantly more active in supporting adhesion of all cells tested. Increased adhesion 341
was associated with higher release of H2O2 by human monocytes indicating increased 342
activation. A387 TSP4 produced by macrophages supported both adhesion and 343 migration as was demonstrated with peritoneal macrophages, but P387 produced by 344 macrophages only affected adhesion without any effect on migration. The sources of 345
TSPs are known to affect their effects, because the cellular effects depend on 346
interactions of TSPs with other ECM ligands produced by cells. Cell-produced TSPs 347 may exhibit different effects than exogenous purified recombinant TSP4. However, the 348 supportive effects of TSP4, especially P387 TSP4, on adhesion have been consistent 349 across all cell types tested. (green) and pro-resolving CD38 (magenta) markers were stained with corresponding 501
antibodies as described in Methods. B: CD68 (green) and Egr2 (magenta). 502
Immunofluoresecnce, confocal microscopy. 503 (graph in the left), arteries without lesions (graph in the middle), and arteries with 530 atherosclerotic lesions (graph in the right); WT (n=12) and heterozygous human 531 arteries (HT, n=12). B: Macrophages (CD68) in tunica intima of human arteries. C: 532
Macrophages (CD68) immunostaining in tunica adventitia. 533
Figure 7. P387 TSP4 is more active in supporting adhesion of macrophages. A: 534
Macrophage-like cells WBC264-9C and B: human monocytes purified from blood were 535 plated in the cell culture dish coated with purified recombinant A387 TSP4 or P387 TSP4; 536 n=3, p<0.05. C: Mouse peritoneal macrophages (MPM) from WT, Thbs4 −/− , and P387-537
TSP4 KI mice treated with LPS (0.25 µg/g) for 72h were added to 24-well plates and 538 incubated at 37°C for 1h (left, adhesion). Unattached cells were removed by washing, 539 and the remaining DNA in the wells was measured using the CyQUANT reagent, n=12, 540 *p<0.05. Right: Migration of MPM was measured Boyden chambers, 4h at 37°C, n=12, 541 *p<0.05. 542 543 
